Cargando…
Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study
BACKGROUND: Although more than a year past since COVID-19 was defined, there is no specific treatment yet. Since COVID-19 management differs over time, it is hard to determine which therapy is more efficacious. In this study, we aimed to evaluate the efficacy of the regimen with Favipiravir (FPV) an...
Autores principales: | Ucan, Anıl, Cerci, Pamir, Efe, Serdar, Akgun, Hakan, Ozmen, Ahmet, Yagmuroglu, Aysel, Bilgin, Muzaffer, Avci, Deniz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148395/ https://www.ncbi.nlm.nih.gov/pubmed/34034765 http://dx.doi.org/10.1186/s12985-021-01577-1 |
Ejemplares similares
-
Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19
por: Bayram, Mehmet, et al.
Publicado: (2021) -
Traumatic coccydynia patients benefit from coccygectomy more than patients undergoing coccygectomy for non-traumatic causes
por: Kara, Deniz, et al.
Publicado: (2023) -
Effects of Vitamin C on the Oral-Nasal Mucosal Damage Caused by Favipiravir in Old and Young Rats
por: Kurt, Yücel, et al.
Publicado: (2022) -
Evaluation of the Effects of Favipiravir Combined with Vitamin C on Alveolar Bone in Rats
por: Lektemur Alpan, A., et al.
Publicado: (2022) -
Erratum to: Evaluation of the Effects of Favipiravir Combined with Vitamin C on Alveolar Bone in Rats
por: Alpan, A. Lektemur, et al.
Publicado: (2022)